Clinical Trials Logo
  1. Home
  2. Extracorporeal Life Support
  3. NCT05146336

CytOSorb TreatMent Of Critically Ill PatientS Registry — COSMOS  

Sepsis Clinical Trial

Official title:
CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting

Clinical Trial Summary

Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Acute Liver Failure
  • Acute Lung Injury
  • Acute on Chronic Liver Failure
  • Acute Respiratory Distress Syndrome
  • Acute-On-Chronic Liver Failure
  • Burns
  • Cardiogenic Shock
  • Communicable Diseases
  • Cytokine Release Syndrome
  • Drug Overdose
  • End Stage Liver Disease
  • Endocarditis
  • Extracorporeal Life Support
  • Hemophagocytic Lymphohistiocytoses
  • Hepatic Insufficiency
  • Infections
  • Infectious Disease
  • Liver Failure
  • Liver Failure, Acute
  • Liver Transplant; Complications
  • Lymphohistiocytosis, Hemophagocytic
  • Pancreatitis
  • Postoperative Vasoplegic Syndrome
  • Respiratory Distress Syndrome
  • Respiratory Distress Syndrome, Newborn
  • Rhabdomyolysis
  • Sepsis
  • Septic Shock
  • Shock
  • Shock, Cardiogenic
  • Syndrome
  • Trauma
  • Vasoplegia
Clinical Trial Details
NCT number NCT05146336
Study type Observational [Patient Registry]
Source CytoSorbents, Inc
Contact Marie-Christin Pawlik, PhD
Phone +49 30 654 99 145
Email cosmos@cytosorbents.com
Status Recruiting
Phase
Start date June 22, 2022
Completion date September 2032
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3